A family from Co Down are campaigning for access to better support services after their dad's death from a rare form of cancer earlier this year.
A family from Co Down are campaigning for access to better support services after their dad's death from a rare form of cancer earlier this year.
"The idea that what dad had being due to asbestos had been thrown about, but we felt relatively reassured at the beginning thinking there was no way he could have this because he hadn't been in contact with asbestos, but unfortunately that's what it turned out to be. She said: "My dad was incredibly fit, he was fitter than me to be honest. He would've walked for miles every day.
"He has three daughters then my mummy, so there were five of us in the family. Four girls tucking around him all the time, he never got a minute's peace, he was tortured with all of us," she added. On average, people who are diagnosed with mesothelioma pass away within 12 months. Niamh puts her dad's fight of four and a half years against the disease down to his outlook on life.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Brave brain cancer survivor Alfie, 12, enters our Xmas Cards For Kids campaignBRAVE Alfie Hinks is still learning to walk and talk again after surviving a satsuma-sized brain tumour. But this week the 12-year-old was beaming in his bedroom as he entered our Xmas Cards For Ki…
Read more »
Government must increase bill discount to £1k, watchdog saysWhich? claimed that the current financial support package on offer is not enough to protect families from financial distress
Read more »
Dog-loving dad's A&E death one day after suffering fall at homeGuy Curtis was diagnosed with underlying leukaemia hours before he passed away at Royal Blackburn Hospital
Read more »
Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients - Genome MedicineBackground Genetic testing (GT) for hereditary cancer predisposition is traditionally performed on selected genes based on established guidelines for each cancer type. Recently, expanded GT (eGT) using large hereditary cancer gene panels uncovered hereditary predisposition in a greater proportion of patients than previously anticipated. We sought to define the diagnostic yield of eGT and its clinical relevance in a broad cancer patient population over a 5-year period. Methods A total of 17,523 cancer patients with a broad range of solid tumors, who received eGT at Memorial Sloan Kettering Cancer Center between July 2015 to April 2020, were included in the study. The patients were unselected for current GT criteria such as cancer type, age of onset, and/or family history of disease. The diagnostic yield of eGT was determined for each cancer type. For 9187 patients with five common cancer types frequently interrogated for hereditary predisposition (breast, colorectal, ovarian, pancreatic, and prostate cancer), the rate of pathogenic/likely pathogenic (P/LP) variants in genes that have been associated with each cancer type was analyzed. The clinical implications of additional findings in genes not known to be associated with a patients’ cancer type were investigated. Results 16.7% of patients in a broad cancer cohort had P/LP variants in hereditary cancer predisposition genes identified by eGT. The diagnostic yield of eGT in patients with breast, colorectal, ovarian, pancreatic, and prostate cancer was 17.5%, 15.3%, 24.2%, 19.4%, and 15.9%, respectively. Additionally, 8% of the patients with five common cancers had P/LP variants in genes not known to be associated with the patient’s current cancer type, with 0.8% of them having such a variant that confers a high risk for another cancer type. Analysis of clinical and family histories revealed that 74% of patients with variants in genes not associated with their current cancer type but which conferred a high risk for ano
Read more »
The Marriage Portrait by Maggie O'Farrell is just as vivid and spellbinding as HamnetThis dazzling story set in Renaissance Italy proves the Women's Prize-winning author just gets better and better
Read more »